中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
7期
215-216
,共2页
糖尿病周围神经病变%前列地尔%α- 硫辛酸
糖尿病週圍神經病變%前列地爾%α- 硫辛痠
당뇨병주위신경병변%전렬지이%α- 류신산
Diabetic peripheral neuropathy%Alprosladil%α-lipoic acid
目的：观察前列地尔联合α-硫辛酸治疗糖尿病周围神经病变的临床疗效。方法选择糖尿病周围神经病变患者48例，给予前列地尔联合α-硫辛酸治疗3周，观察患者治疗前后的症状及神经传导速度变化。结果治疗总有效率为93%，肌电图显示，治疗前后神经传导速度有明显改善，治疗前后数据对比有统计学意义（P<0.05）。结论前列地尔联合α-硫辛酸能有效地促进神经损伤的恢复，疗效确切。
目的：觀察前列地爾聯閤α-硫辛痠治療糖尿病週圍神經病變的臨床療效。方法選擇糖尿病週圍神經病變患者48例，給予前列地爾聯閤α-硫辛痠治療3週，觀察患者治療前後的癥狀及神經傳導速度變化。結果治療總有效率為93%，肌電圖顯示，治療前後神經傳導速度有明顯改善，治療前後數據對比有統計學意義（P<0.05）。結論前列地爾聯閤α-硫辛痠能有效地促進神經損傷的恢複，療效確切。
목적：관찰전렬지이연합α-류신산치료당뇨병주위신경병변적림상료효。방법선택당뇨병주위신경병변환자48례，급여전렬지이연합α-류신산치료3주，관찰환자치료전후적증상급신경전도속도변화。결과치료총유효솔위93%，기전도현시，치료전후신경전도속도유명현개선，치료전후수거대비유통계학의의（P<0.05）。결론전렬지이연합α-류신산능유효지촉진신경손상적회복，료효학절。
Objective To observe the curative clinical effects that α-lipoic acid combined with alprosladil have on diabetic peripheral neuropathy(DPN). Methods A total of 48 cases diabetic peripheral neuropalhy patients were selected. The group was given α-lipoic Acid and alprostadil three weeks. Results The total effective rate of the group was 93%. The EMG results showed that the nerve conduction velocity on the group was better than that before treatment. Comparing the data after treatment was statistical y significant(P<0.05). Conclusion α-lipoic acid combined alprosladil is effective by promoting the sensory and motoring nerve conduction velocity recovery.
